Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects

- Cognitive Impairment
- Completed

Study Title: Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects

Teva Identifier: C26401/1111 | 2013-001883-51

ClinicalTrials.gov Identifier: NCT01903824

Study Status: Completed

Trial Condition(s): Cognitive Impairment

Interventions: Drug: CEP-26401 | Drug: donepezil hydrochloride | Drug: modafinil | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult

Age Range: 18 Years to 50 Years

Trial Duration: 08/01/2013 - 12/01/2013

Phase: Phase 1

Study Type

Interventional